Literature DB >> 22943910

[Trend analysis and prediction of cancer incidence in China].

Wan-qing Chen1, Rong-shou Zheng, Hong-mei Zeng, Si-wei Zhang, Ni Li, Xiao-nong Zou, Jie He.   

Abstract

OBJECTIVE: Based on the national cancer incidence database from 1998 to 2007, to analyze the cancer incidence trend and predict the cancer burden between 2008 and 2015.
METHODS: We picked up the cancer incidence data of 40 cancer registry sites from National Central Cancer Registry Database between 1998 and 2007. In total, 1 109 594 cancer cases were registered, covering 446 734 668 person-year. The separate incidence by district and gender were calculated, and the standardized incidence rate was calculated by world's population age structure. The incidence trend between the 10 years was analyzed by JoinPoint software, as well as the age-percentage-changes (APC). Age-Period-Cohort Bayesian Model was applied to fit the cancer incidence data stratified by age, district and gender. The cancer incidence between 2008 and 2015 was then predicted.
RESULTS: During the period of 1998 - 2007, in urban areas, the male cancer incidence rate was 277.61/100 000 (472 307/170 131 309), with the age standardized rate (ASR) at 202.05/100 000; while the female cancer incidence rate was 236.35/100 000 (389 586/164 830 893), with the ASR at 159.15/100 000; in rural areas, the male and female cancer incidence rates were separately 272.23/100 000 (153 478/56 377 236) and 170.09/100 000 (94 223/55 395 230), with the corresponding ASR at 244.34/100 000 and 137.90/100 000. Crude incidence rate in urban men increased from 247.00/100 000 (27 758/11 237 967) in 1998 to 305.76/100 000 (68 953/22 551 353) in 2007; while it increased from 207.37/100 000 (22 476/10 838 355) to 263.20/100 000 (58 055/22 057 787) among urban women. The crude incidence rate in rural men increased from 232.33/100 000 (10 045/4 323 628) to 303.65/100 000 (23 313/7 677 484) and it increased from 139.03/100 000 (5836/4 197 806) to 197.40/100 000 (14 850/7 522 690) among rural women. After age adjustment, the urban male APC value (95%CI) was 0.5% (-0.2% - 1.3%), showed no significantly statistical difference. However, the urban female APC value (95%CI), rural male APC value (95%CI) and rural female APC value (95%CI) were separately 1.7% (1.3% - 2.0%), 1.8% (0.9% - 2.6%) and 2.8% (1.8% - 3.7%), all showed an obvious uptrend. The outcome of Age-Period-Cohort Bayesian model predicted that by year 2015, the incidence cancer rate in urban areas will reach 309.13/100 000 (1.140 million new cases) among males and 303.79/100 000 (1.046 million new cases) among females; while in rural areas the rate will reach 288.66/100 000 (1.019 million new cases) among males and 222.59/100 000 (0.734 million new cases) among females.
CONCLUSION: The cancer incidence has increased annually; the uptrend in rural areas was more obvious than it in urban areas; the uptrend in females was more obvious than it in males. It is predicted that the annual incidence will continue to increase in the next years, and effective control programs should be carried out immediately.

Entities:  

Mesh:

Year:  2012        PMID: 22943910

Source DB:  PubMed          Journal:  Zhonghua Yu Fang Yi Xue Za Zhi        ISSN: 0253-9624


  6 in total

1.  Elevated serum soluble interleukin-2 receptor levels increase malignancy-related risk in patients on chronic hemodialysis.

Authors:  Chen XiaoHong; Shen Bo; Xiang FangFang; Guo Man; Zou JianZhou; Liu ZhongHua; Lv WenLv; Cao XueSen; Ding XiaoQiang; Zhang Boheng
Journal:  Int J Clin Oncol       Date:  2019-06-10       Impact factor: 3.402

Review 2.  Advances in non-surgical management of primary liver cancer.

Authors:  Xiao Chen; Hai-Peng Liu; Mei Li; Liang Qiao
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

3.  Incidence and mortality of gynaecological cancers: Secular trends in urban Shanghai, China over 40 years.

Authors:  Zhezhou Huang; Ying Zheng; Wanqing Wen; Chunxiao Wu; Pingping Bao; Chunfang Wang; Weijian Zhong; Yu-Tang Gao; Fan Jin; Yong-Bing Xiang; Xiao-Ou Shu; Alicia Beeghly-Fadiel
Journal:  Eur J Cancer       Date:  2016-05-26       Impact factor: 9.162

4.  A phase I clinical trial of dose escalation of lobaplatin in combination with fixed-dose docetaxel for the treatment of human solid tumours that had progressed following chemotherapy.

Authors:  Yu Peng; Yue-E Liu; Xiao-Can Ren; Xue-Ji Chen; Hui-Ling Su; Jie Zong; Zeng-Li Feng; Dong-Ying Wang; Qiang Lin; Xian-Shu Gao
Journal:  Oncol Lett       Date:  2014-11-05       Impact factor: 2.967

Review 5.  Coevolution between Cancer Activities and Food Structure of Human Being from Southwest China.

Authors:  Yawen Zeng; Juan Du; Xiaoying Pu; Jiazhen Yang; Tao Yang; Shuming Yang; Xiaomeng Yang
Journal:  Biomed Res Int       Date:  2015-11-01       Impact factor: 3.411

6.  [Association of Inorganics Accumulation with the Activation of NF-κB Signaling Pathway and the iNOS Expression of Lung Tissue in Xuanwei Lung Cancer Patients].

Authors:  Jiapeng Yang; Guangjian Li; Yunchao Huang; Lianhua Ye; Yongchun Zhou; Guangqiang Zhao; Yujie Lei; Xiaobo Chen; Kun Wang; Ying Chen; Chun Dai; Yanjun Zhang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2016-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.